Lai et al. (2010) showed that LMP1 activated both canonical and non-canonical NF-κB pathways in NPC cell lines by using LMP1 mutants to determine the necessity of various CTARs for particular signalling pathway variants [110]. The gene discussed is NFKB1; the disease is nasopharyngeal carcinoma.